PE-backed ProPharma acquires Southwood Research

ProPharma Group, a portfolio company of Linden Capital Partners, has acquired UK-based Southwood Research, a provider of regulatory science services to the pharmaceutical and biotech industries. No financial terms were disclosed.

11 March 2019•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles